These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 29037241)

  • 1. The potassium channel KCa3.1 constitutes a pharmacological target for astrogliosis associated with ischemia stroke.
    Yi M; Wei T; Wang Y; Lu Q; Chen G; Gao X; Geller HM; Chen H; Yu Z
    J Neuroinflammation; 2017 Oct; 14(1):203. PubMed ID: 29037241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted inhibition of KCa3.1 attenuates TGF-β-induced reactive astrogliosis through the Smad2/3 signaling pathway.
    Yu Z; Yu P; Chen H; Geller HM
    J Neurochem; 2014 Jul; 130(1):41-49. PubMed ID: 24606313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ca
    Yu Z; Dou F; Wang Y; Hou L; Chen H
    J Neuroinflammation; 2018 Nov; 15(1):316. PubMed ID: 30442153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KCa3.1 constitutes a pharmacological target for astrogliosis associated with Alzheimer's disease.
    Yi M; Yu P; Lu Q; Geller HM; Yu Z; Chen H
    Mol Cell Neurosci; 2016 Oct; 76():21-32. PubMed ID: 27567685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KCa3.1 Inhibition Switches the Astrocyte Phenotype during Astrogliosis Associated with Ischemic Stroke Via Endoplasmic Reticulum Stress and MAPK Signaling Pathways.
    Yu Z; Yi M; Wei T; Gao X; Chen H
    Front Cell Neurosci; 2017; 11():319. PubMed ID: 29075181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the KCa3.1 channel contributes to traumatic scratch injury-induced reactive astrogliosis through the JNK/c-Jun signaling pathway.
    Yi M; Dou F; Lu Q; Yu Z; Chen H
    Neurosci Lett; 2016 Jun; 624():62-71. PubMed ID: 27163196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potassium channel KCa3.1 constitutes a pharmacological target for neuroinflammation associated with ischemia/reperfusion stroke.
    Chen YJ; Nguyen HM; Maezawa I; Grössinger EM; Garing AL; Köhler R; Jin LW; Wulff H
    J Cereb Blood Flow Metab; 2016 Dec; 36(12):2146-2161. PubMed ID: 26661208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KCa3.1 deficiency attenuates neuroinflammation by regulating an astrocyte phenotype switch involving the PI3K/AKT/GSK3β pathway.
    Wei T; Wang Y; Xu W; Liu Y; Chen H; Yu Z
    Neurobiol Dis; 2019 Dec; 132():104588. PubMed ID: 31470105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potassium channel KCa3.1 represents a valid pharmacological target for microgliosis-induced neuronal impairment in a mouse model of Parkinson's disease.
    Lu J; Dou F; Yu Z
    J Neuroinflammation; 2019 Dec; 16(1):273. PubMed ID: 31878950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Potassium Channel KCa3.1 Represents a Valid Pharmacological Target for Astrogliosis-Induced Neuronal Impairment in a Mouse Model of Alzheimer's Disease.
    Wei T; Yi M; Gu W; Hou L; Lu Q; Yu Z; Chen H
    Front Pharmacol; 2016; 7():528. PubMed ID: 28105015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood-brain barrier KCa3.1 channels: evidence for a role in brain Na uptake and edema in ischemic stroke.
    Chen YJ; Wallace BK; Yuen N; Jenkins DP; Wulff H; O'Donnell ME
    Stroke; 2015 Jan; 46(1):237-44. PubMed ID: 25477223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibiting cell cycle progression reduces reactive astrogliosis initiated by scratch injury in vitro and by cerebral ischemia in vivo.
    Zhu Z; Zhang Q; Yu Z; Zhang L; Tian D; Zhu S; Bu B; Xie M; Wang W
    Glia; 2007 Apr; 55(5):546-58. PubMed ID: 17243097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of KCa3.1 potassium channels protects against cisplatin-induced acute kidney injury.
    Chen CL; Liao JW; Hu OY; Pao LH
    Arch Toxicol; 2016 Sep; 90(9):2249-2260. PubMed ID: 26438401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repurposing the K
    Lee RD; Chen YJ; Nguyen HM; Singh L; Dietrich CJ; Pyles BR; Cui Y; Weinstein JR; Wulff H
    Transl Stroke Res; 2024 Jun; 15(3):518-532. PubMed ID: 37088858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRPV4 channels contribute to calcium transients in astrocytes and neurons during peri-infarct depolarizations in a stroke model.
    Rakers C; Schmid M; Petzold GC
    Glia; 2017 Sep; 65(9):1550-1561. PubMed ID: 28639721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blocking epidermal growth factor receptor attenuates reactive astrogliosis through inhibiting cell cycle progression and protects against ischemic brain injury in rats.
    Yang Q; Wang EY; Huang XJ; Qu WS; Zhang L; Xu JZ; Wang W; Tian DS
    J Neurochem; 2011 Nov; 119(3):644-53. PubMed ID: 21883215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of p38 MAPK in reactive astrogliosis induced by ischemic stroke.
    Roy Choudhury G; Ryou MG; Poteet E; Wen Y; He R; Sun F; Yuan F; Jin K; Yang SH
    Brain Res; 2014 Mar; 1551():45-58. PubMed ID: 24440774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salidroside Inhibits Reactive Astrogliosis and Glial Scar Formation in Late Cerebral Ischemia via the Akt/GSK-3β Pathway.
    Dong C; Wen S; Zhao S; Sun S; Zhao S; Dong W; Han P; Chen Q; Gong T; Chen W; Liu W; Liu X
    Neurochem Res; 2021 Apr; 46(4):755-769. PubMed ID: 33389472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactive astrogliosis in stroke: Contributions of astrocytes to recovery of neurological function.
    Sims NR; Yew WP
    Neurochem Int; 2017 Jul; 107():88-103. PubMed ID: 28057555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sevoflurane postconditioning attenuates reactive astrogliosis and glial scar formation after ischemia-reperfusion brain injury.
    Zhu YM; Gao X; Ni Y; Li W; Kent TA; Qiao SG; Wang C; Xu XX; Zhang HL
    Neuroscience; 2017 Jul; 356():125-141. PubMed ID: 28501505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.